Advanced search
Publication Cover
International Journal of Neuroscience Volume 120, 2010 - Issue 4
Submit an article Journal homepage
106
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Adherence to Disease-Modifying Drugs in Patients with Multiple Sclerosis: A Consensus Statement from the Middle East MS Advisory Group

Bassem I. YamoutInternal Medicine, American University of Beirut, Beirut, LebanonCorrespondence[email protected]
,
Maurice DahdalehDepartment of Neurology, Arab Medical Centre, Amman, Jordan
,
Mohammed Ali Al JumahKing Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
,
Suhail Al-ShammriNeurology Division, Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
,
Isa Al SharoqiNeurology Unit, Salamaniya Medical Complex, Manama, Bahrain
,
Abdel Rahman Al-TahanNeurology Section, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
,
Saeed BohlegaDepartment of Neuroscience, King Faisal Specialist Hospital and Research Center., Riyadh, Saudi Arabia
,
Dirk DeleuDepartment of Neurology (Medicine), Hamad Medical Corporation, Doha, Qatar
,
Jihad InshasiDepartment of Neurology, Rashid Hospital, Dubai Health Authority Dubai, United Arab Emirates and Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
,
Ahmad KhalifaDepartment of Neurology, Damascus Hospital, Damascus, Syrian Arab Republic
&
Miklos SzólicsDivision of Neurology, Tawam Hospital in affiliation with Johns Hopkins Medicine, Al Ain, Abu Dhabi Emirate, United Arab Emirates
 show all
Pages 273-279 | Received 03 Aug 2009, Published online: 08 Apr 2010
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

ABSTRACT

Adherence to therapy is a key issue in chronic illnesses. In addition, several features of multiple sclerosis (MS) and its treatment may increase the likelihood of patient nonadherence and discontinuation of treatment. Nonadherence will obviously compromise the efficacy of disease-modifying drugs in patients with MS. This subject was discussed by a group of local MS specialists from the Middle East. The group debated several key questions about the features and causes of patient nonadherence and its management. Further, they made recommendations for optimizing treatment adherence in this area.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,997.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.